These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 26507436)
1. Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease. Busch EL; Keku TO; Richardson DB; Cohen SM; Eberhard DA; Avery CL; Sandler RS Clin Exp Metastasis; 2016 Jan; 33(1):53-62. PubMed ID: 26507436 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. Busch EL; Don PK; Chu H; Richardson DB; Keku TO; Eberhard DA; Avery CL; Sandler RS BMC Cancer; 2018 Jan; 18(1):82. PubMed ID: 29338703 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
5. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. Jaca A; Govender P; Locketz M; Naidoo R J Clin Pathol; 2017 Apr; 70(4):331-356. PubMed ID: 27672217 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival. Liu J; Chen L; Deng H; Xu B; Li M; Zheng X; Wu C; Jiang J Int J Clin Exp Pathol; 2014; 7(10):6943-9. PubMed ID: 25400779 [TBL] [Abstract][Full Text] [Related]
8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011 [TBL] [Abstract][Full Text] [Related]
9. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1. Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192 [TBL] [Abstract][Full Text] [Related]
10. Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma. Lee SJ; Yang CS; Kim DD; Kang YN; Kwak SG; Park JB; Cho CH; Park KK Int J Clin Exp Pathol; 2015; 8(11):14270-82. PubMed ID: 26823743 [TBL] [Abstract][Full Text] [Related]
11. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer. Jang TJ Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145 [TBL] [Abstract][Full Text] [Related]
12. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628 [TBL] [Abstract][Full Text] [Related]
13. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer. Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478 [TBL] [Abstract][Full Text] [Related]